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population in SHI, which may make this system more
complicated rather than helpful. 
Conclusion
Given present human resource constraints and
institutional capacities, operationalizing any
government funded SHI scheme on a national level
ensuring universal coverage is a huge challenge.
Positive vibes are a rising national economy, political
will to carry out health sector reforms and the creation of
district health system after devolution. The current
scenario is ideal to pilot small initiatives, may be at
district levels, and then up scale by learning lessons
from these pilot projects. Policy makers, health systems
specialists and other stakeholders must capitalize on
these opportunities and windows to find a way out. 
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Case Report
Cardiac Tamponade after removal of temporary pace maker in multidiscipinary
Intensive Care Unit
Muhammad Faisal Khan1,  Ali Bin Sarwar Zubairi2
Department of Anesthesiology1, Pulmonary and Critical Care Medicine2, Aga  Khan University Hospital, Karachi.
Abstract
Cardiac tamponade is a medical and surgical
emergency, which needs early recognition and treatment.
Myocardial perforation leading to cardiac tamponade is a
rare complication after pace maker insertion. We are
reporting a case of cardiac tamponade after removal of
temporary pace maker in a multidisciplinary intensive
care unit.
Introduction
Cardiac tamponade is a medical emergency which is
characterized by the accumulation of fluid in the pericardial
space, resulting in reduced ventricular filling and
subsequent haemodynamic compromise. Myocardial
perforation leading to cardiac tamponade is a rare
complication after pace maker insertion. This condition
requires urgent recognition since the prompt drainage of the
pericardial fluid may be lifesaving. We present a case report
of myocardial perforation complicated by cardiac
tamponade after removal of a pacemaker which was
successfully managed surgically.
Case Report
A 60 year-old female with hypertension, diabetes
mellitus and ischaemic heart disease with mild to moderate
systolic dysfunction, was admitted through emergency
room with cardiogenic shock due to Non-ST elevated MI
(Troponin I >3), hyponatraemia (Na = 123 Meq/L)  and
severe metabolic acidosis. She was intubated in emergency
room due to respiratory distress. Post intubation, she went
into cardiac arrest. Temporary pacemaker was inserted in
the emergency room (Figure) and she was transferred to
intensive care unit (ICU). She was successfully extubated
on day 4. Patient regained her own heart rhythm 24 hours
after insertion of pacemaker as shock and metabolic
acidosis improved. Within one hour of removal of
pacemaker she complained of dizziness and difficulty in
breathing. Blood pressure was 60/40 mmHg and heart rate
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90/min. Pulse was weak. EKG showed low voltage waves
with ST depression in V3 to V5. Urgent echocardiogram
showed large pericardial effusion with tamponade. She was
resuscitated with IV fluids and immediate
pericardiocentesis was performed and 400 ml of clotted
blood was removed. Pericardial window was made. Patient
became haemodynamically stable and was extubated on the
next day and shifted to special care unit. She was discharged
home seven days after the event.
Discussion
Myocardial perforation is a rare complication
following pacemaker implantation that may cause cardiac
tamponade. If it does occur, it is usually at the time of lead
insertion.1 Tamponade usually takes place due to arrow
head endocardial electrode.2 Fatal myocardial perforation
can occur with this electrode and the apex of the right
ventricle should be avoided as the site of insertion3. This
condition requires urgent recognition since the prompt
drainage of the pericardial fluid may be lifesaving.
The pericardium consists of a thin serous membrane
covering the epicardial surface (visceral pericardium) and a
serous membrane-lined fibrous sac (parietal pericardium),
which has limited elastic properties. The pericardial space
separates the two layers and contains approximately 25-35
ml of serous fluid.1 An acute accumulation of pericardial
fluid of greater than 100 ml will produce haemodynamic
effects of tamponade whereas a chronic pericardial
collection of fluid up to 2000 ml may occur without
imposing any effect upon cardiac output.2
Cardiac tamponade is defined as a
haemodynamically significant cardiac compression caused
by pericardial fluid.3 The fluid may be blood, pus, effusion
or air.4 Pericardial tamponade may arise from multiple
traumatic and non traumatic etiologies, resulting in
unrecognized rapid deterioration and often death.
Traumatic pericardial tamponade occurs in only 2% of all
penetrating chest injuries5, and rarely is the result of blunt
trauma. Mortality exceeds 60% if cardiac arrest occurs.6
Non traumatic causes of pericardial tamponade include
haemopericardium due to anticoagulant therapy or as a rare
complication of acute myocardial infarction. In addition,
various non- traumatic causes such as infection, drugs,
neoplasm, uraemia, myxoedema, collagen vascular disease,
and hypersensitivity states may produce large effusion with
tamponade. Pericardial tamponade has resulted from
cardiac catheterization, central venous catheterization,
pericardiocentesis, intracardiac injection, cardiac surgery,
and sternal bone biopsy and transvenous pacemaker
insertion.7 Common sites of perforation are the right atrium
and right ventricle followed by superior vena cava.8
Perforation has also been reported in the left atrium (patent
foramen ovale) and the left pericardiophrenic vein.
Endocardial injury is thought to be caused by either
movement of the catheter tip, by movements of cardiac
chambers and lower superior vena cava (cardiac cycle) or
by direct trauma. Injury causes thrombus formation and
eventually adherence of the wire to the endocardium.
Erosion occurs which may lead to perforation. 
Early recognition and treatment of cardiac
tamponade is essential to prevent fatal outcome. Symptoms
and signs are usually sudden and include nausea, fatigue,
light-headedness, dyspnoea, retrosternal chest pain,
cyanosis, venous engorgement, pulsus paradoxus and
confusion. The most common findings noted by Nasim and
colleagues9 from case reports were hypotension (88%),
raised central venous pressure (70%) and a disturbance in
cardiac rhythm (67%) mainly tachycardia. However in 29%
of these cases death occurred suddenly after 'vague
premonitory signs'. Diagnosis of cardiac tamponade is
difficult in sedated, ventilated and post-operative patients.
EKG and chest radiograph findings may not always
assist the diagnosis. EKG findings such as low voltage QRS
complex or electrical alternans may not always be present.
Chest radiograph may not show abnormalities until
considerable fluid has accumulated in the pericardial sac.
Transthoracic or transesophageal echocardiography is
diagnostic. These techniques are unfortunately not always
available and delaying treatment to obtain these
investigations may be fatal.
The patient is initially resuscitated with intravenous
fluids to promote maximum filling of the heart. In general,
inotropic agents that increase the stroke volume and support
Figure 1. Portable Chest X-Ray showing ET tube, right IJ swan sheath and temporary pacemaker
in appropriate position. Lung fields show mild bilateral pleural effusions, silhouetting of left hemi
diaphragm and haze over both lower lung zones consistent with pulmonary edema.
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systemic resistance are used, although some recommend
isoprenaline, as it reduces the cardiac size and diminishes the
effective degree of tamponade while increasing cardiac
output.2 The definitive treatment of cardiac tamponade is the
removal of cardiac diastolic restriction by either
pericardiocentesis or thoracotomy. Pericardiocnetesis is
usually performed for urgent management of an acute
tamponade (the acute removal of as little as 50 ml of fluid is
often sufficient to correct the hypotension). A thoracotomy is
often required when a tamponade exists following coronary
artery bypass grafting, penetrating or closed cardiac trauma
and aortic dissection. It is also indicated when
pericardiocentesis has failed to relieve the tamponade. 
Conclusion
Cardiac tamponade is a life-threatening emergency.
Immediate recognition and treatment are imperative if a
disastrous outcome is to be prevented.
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Case Report
De novo primary squamous cell carcinoma of the ovary: A case of a rare
malignancy with an aggressive clinical course
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Abstract
Ovarian squamous cell carcinoma is a rare
malignancy and the occurrence is attributable to malignant
transformation of an existing ovarian dermoid cyst. The de
novo occurrence of squamous cell carcinoma of the ovary,
in the absence of an antecedent ovarian dermoid, is
extremely rare. The case of a 31 year old Asian woman,
evaluated for abdominal distension and discomfort is
presented. Abdominal CT was suggestive of a malignant
neoplastic process. Laparotomy confirmed a malignant
tumour with involvement of the right adnexa and extension
into the omentum and bowel. Surgical debulking,
hysterectomy, bilateral salpingo-ophorectomy and total
omentectomy and bowel resection was performed.
Histopathology demonstrated squamous cell carcinoma
arising from the right ovary with no co-existing ovarian
dermoid. The postoperative period was significant for
disease progression despite adjuvant chemotherapy. 
Introduction
Squamous cell carcinoma of the ovary is a rare
clinical entity, accounting for less than 1% of all malignant
tumours of the ovary.1 Malignant transformation of a pre-
existing mature cystic teratoma (dermoid cyst) is
appreciated as the underlying pathophysiological
mechanism, and this phenomenon is considered rare, as
only 1-2% of teratomas demonstrate this change.1 The de
novo development of a primary squamous carcinoma, in an
otherwise healthy ovary is an extremely rare occurrence.2-5
We present a case of this rare malignancy, not been
previously reported in the Southeast Asian population, with
a review of literature.
Case Report
A 31 year old, para 2, Asian female (Pakistani
heritage) was referred to the general surgery clinic with a
one year history of progressive abdominal discomfort and
distension.  She had a history of weight loss with no change
in appetite, bowel habit or menstrual flow. A recent pap
smear was negative for dysplasia. On examination, she was
anaemic with no jaundice, lymphadenopathy and had
normal breast examination. Abdominal examination
revealed a firm, mildly tender, mobile mass occupying most
of the lower abdomen. There was no clinical evidence of
ascites. Pelvic and rectal exams were unremarkable. 
Pre-operative evaluation showed anaemia with
normal cell counts, and normal kidney and liver functions.
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